Table 3.
Change of FA, % | Study 1 Echium oil (n = 59) | Study 2 Linseed oil mixture (n = 59) | Treatment effect EO vs. LO P2 | Control groups | ||
---|---|---|---|---|---|---|
Fish oil (n = 19) | Olive oil (n = 18) | |||||
Plasma | ||||||
n-3 PUFA | ALA | 230 ± 13b† | 314 ± 20a† | 0.001 | −8 ± 4c | 14 ± 5c† |
SDA | 789 ± 69a† | 159 ± 13b† | <0.001 | 59 ± 19b† | 22 ± 14b | |
ETA | 406 ± 32a† | 124 ± 10b† | <0.001 | 53 ± 12b† | 27 ± 10b† | |
EPA | 168 ± 8b† | 67 ± 6c† | <0.001 | 646 ± 75a† | 4 ± 6d | |
DPA | 68 ± 4b† | 31 ± 3c† | <0.001 | 113 ± 13a† | −1 ± 2d | |
DHA | −3 ± 3b | −11 ± 2b† | 0.008 | 39 ± 8a† | −5 ± 3b | |
n-6 PUFA | LA | −9 ± 1b† | 3 ± 1a† | <0.001 | −13 ± 2b† | −8 ± 1b† |
GLA | 276 ± 23a† | −11 ± 3b† | <0.001 | −16 ± 4b† | 7 ± 6b | |
DGLA | 67 ± 5a† | −10 ± 2bc† | <0.001 | −26 ± 4c† | 6 ± 3b | |
AA | 14 ± 2a† | −1 ± 2b | <0.001 | 3 ± 3ab | 0 ± 3b | |
22:5n-6 | −20 ± 3b† | −9 ± 3b† | 0.006 | −38 ± 7b† | 12 ± 5a | |
RBC | ||||||
n-3 PUFA | ALA | 156 ± 32b† | 201 ± 9a† | <0.001 | −12 ± 5c | 8 ± 3c† |
SDA | 405 ± 54a† | 135 ± 22b† | <0.001 | 6 ± 13c | 49 ± 35b | |
ETA | 243 ± 22a† | 106 ± 7b† | <0.001 | 24 ± 6c | 9 ± 4c | |
EPA | 85 ± 12b† | 32 ± 4c† | <0.001 | 351 ± 35a† | −10 ± 3d† | |
DPA | 32 ± 8b† | 12 ± 2c† | <0.001 | 75 ± 16a† | −4 ± 2d | |
DHA | −4 ± 2b† | −10 ± 2b† | 0.15 | 10 ± 9a | −9 ± 2b† | |
n-6 PUFA | LA | 11 ± 3a | 1 ± 1b | <0.001 | −11 ± 4b | −4 ± 1b† |
GLA | 144 ± 16a† | 0 ± 4b | <0.001 | 1 ± 2b | 7 ± 6b | |
DGLA | 48 ± 9a† | −5 ± 1b† | <0.001 | −15 ± 3b | 3 ± 1b | |
AA | 17 ± 3a† | −1 ± 1b | <0.001 | 2 ± 4b | 0 ± 1b | |
22:5n-6 | −2 ± 4a | −4 ± 1a† | 0.43 | −29 ± 5b† | 6 ± 2a | |
PBMC | ||||||
n-3 PUFA | ALA | 147 ± 20b† | 368 ± 28a† | <0.001 | 70 ± 43bc | 13 ± 8c |
SDA | 424 ± 78a† | 103 ± 34b | <0.001 | −2 ± 24b | 47 ± 45b | |
ETA | 388 ± 35a† | 81 ± 5b† | <0.001 | 38 ± 6b† | 27 ± 19b | |
EPA | 97 ± 9b† | 45 ± 5c† | 0.005 | 564 ± 57a† | −1 ± 4d | |
DPA | 42 ± 5b† | 27 ± 2c† | 0.006 | 94 ± 8a† | 3 ± 2c | |
DHA | −20 ± 3b† | −15 ± 1b† | 0.12 | 2 ± 5a | −4 ± 2ab | |
n-6 PUFA | LA | 8 ± 2a | 5 ± 1a | 0.42 | 6 ± 3a | −7 ± 2b† |
GLA | 128 ± 14a† | −1 ± 4b | <0.001 | 12 ± 15b | 7 ± 4b | |
DGLA | 47 ± 17a† | −1 ± 1b† | <0.001 | −15 ± 3b† | 6 ± 2b | |
AA | −2 ± 3a | −2 ± 1a† | 0.92 | −10 ± 2b† | 2 ± 1a | |
22:5n-6 | −17 ± 6a† | −8 ± 2a† | 0.17 | −48 ± 3b† | 8 ± 4a |
1Values are means ± SEM; adjusted means not shown. Change is from day 0 to day 56. EO echium oil, ETA 20:4n-3, eicosatetraenoic acid, LO linseed oil mixture, RBC red blood cells, PBMC peripheral blood mononuclear cells. P values were analyzed using the generalized linear mixed model ANCOVA with sex, age, BMI, baseline value as covariates
2 P values for the treatment effect including only EO and LO groups
abcMeans with different superscript letters are significantly different between all treatments (P ≤ 0.05)
†Within one oil treatment, means are significantly different between day 0 and day 56 (repeated measures; P ≤ 0.05)